Treatment Options for Medulloblastoma
Medulloblastoma is a type of brain cancer that primarily affects children. It is the most common cancerous brain tumor in this age group, accounting for about 1 in 5 pediatric brain tumors.
Medulloblastoma originates from embryonic cells in the cerebellum, which is responsible for coordinating movement and balance. These tumors grow rapidly and can spread aggressively through the cerebrospinal fluid. The diagnosis and treatment of medulloblastoma can be complex due to its aggressive nature and its location within the brain.
The objective of treatment for Medulloblastoma is primarily curative, meaning the goal is to eliminate the tumor while minimizing side effects and preserving quality of life.
The recommended potential treatments for medulloblastoma, starting with the initial treatment, include:
- Surgery: The first and most common treatment for medulloblastoma is surgery. The goal of surgery is to obtain tissue to determine the tumor type and to remove as much tumor as possible without causing more symptoms for the person. The intended impact of surgery is to remove the tumor and reduce symptoms.
- Radiation therapy: After surgery, radiation therapy is usually recommended. This treatment involves using high-energy beams to target and destroy any remaining cancer cells in the brain and spine. It is often necessary because medulloblastoma tends to spread in these areas. Proton beam radiation therapy may be recommended to minimize damage to surrounding organs. The intended impact of radiation therapy is to kill any remaining cancer cells and prevent the spread or recurrence of the tumor.
- Chemotherapy: Depending on the subtype of medulloblastoma and the extent of tumor spread, chemotherapy may be part of the treatment plan. Chemotherapy involves using powerful drugs to kill cancer cells throughout the body. It can be administered orally or intravenously. The intended impact of chemotherapy is to target cancer cells that may have spread beyond the primary tumor site.
- Clinical trials: Participating in clinical trials may also be a potential treatment option for medulloblastoma. These trials involve testing new chemotherapy drugs, targeted therapies, or immunotherapy drugs. Clinical trials aim to improve treatment outcomes and may offer additional options for patients. The intended impact of clinical trials is to explore innovative treatments that could potentially enhance the effectiveness of existing therapies.
It's important to note that these treatment options are decided by a patient's healthcare team based on factors such as age, remaining tumor after surgery, tumor type, and tumor location. Each individual's situation may vary, so it's crucial to seek expert recommendations from a neuro-oncologist with experience in treating medulloblastoma.
As with any medical condition, it is important to consult with a healthcare professional who can provide personalized advice tailored to your specific situation. They will be able to evaluate your individual case and recommend the most appropriate treatment options for you or your loved one with medulloblastoma.